<SEC-DOCUMENT>0001193125-12-463342.txt : 20121109
<SEC-HEADER>0001193125-12-463342.hdr.sgml : 20121109
<ACCEPTANCE-DATETIME>20121109161803
ACCESSION NUMBER:		0001193125-12-463342
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20121109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20121109
DATE AS OF CHANGE:		20121109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OMEROS CORP
		CENTRAL INDEX KEY:			0001285819
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911663741
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34475
		FILM NUMBER:		121193905

	BUSINESS ADDRESS:	
		STREET 1:		1420 5TH AVE
		STREET 2:		SUITE 2600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101
		BUSINESS PHONE:		206-676-5000

	MAIL ADDRESS:	
		STREET 1:		1420 5TH AVE
		STREET 2:		SUITE 2600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d437857d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, DC 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section 13 or 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of 1934
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of earliest event reported): November 9, 2012 </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>OMEROS CORPORATION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Washington</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>001-34475</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>91-1663741</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1420 Fifth Avenue, Suite 2600 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Seattle, Washington 98101 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices, including zip code) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(206)
676-5000 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Registrant&#146;s telephone number, including area code) </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Former name or former address, if changed since last report) </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;2.02 Results of Operation and Financial Condition. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On November&nbsp;9, 2012, Omeros Corporation issued a press release announcing financial results for the three and nine months ended
September&nbsp;30, 2012. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any
filing with the United States Securities and Exchange Commission made by Omeros Corporation, whether made before or after the date hereof, regardless of any general incorporation language in such filing. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01 Financial Statements and Exhibits. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(d) Exhibits. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:28pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit<BR>Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press release dated November&nbsp;9, 2012 relating to Omeros&#146; financial results for the three and nine months ended September&nbsp;30, 2012</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OMEROS CORPORATION</B></FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Gregory A. Demopulos</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gregory A. Demopulos, M.D.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President, Chief Executive Officer, and Chairman of the Board of Directors</FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: November&nbsp;9, 2012 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXHIBIT INDEX </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:28pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit<BR>Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press release dated November 9, 2012 relating to Omeros&#146; financial results for the three and nine months ended September 30, 2012</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d437857dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g437857adex99_1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Omeros Corporation Reports Third Quarter 2012 Financial Results </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Seattle, WA &#150; November&nbsp;9, 2012</B> &#150; Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to
discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the third quarter of 2012. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial Results </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total operating
expenses for the quarter ended September&nbsp;30, 2012 were $14.5 million compared to $7.2 million for the same period in 2011. The increase in operating expenses primarily relates to a one-time litigation settlement payment of $3.95 million, which
our insurance company has agreed to reimburse to us subject to a reservation of rights, increased Phase 3 clinical trial expenses for OMS302 and increased employee expenses, partially offset by a decrease in expenses in connection with preclinical
work for other programs. Given that the $3.95 million that Omeros&#146; insurer has agreed to reimburse had not been received by Omeros as of September&nbsp;30, 2012, that amount is not included in operating expenses for the 2012 period. For the
quarter ended September&nbsp;30, 2012, Omeros reported a net loss of $13.3 million, or $0.51 per share, compared to a net loss of $6.5 million, or $0.29 per share, for the same period in 2011. At September&nbsp;30, 2012, Omeros had cash, cash
equivalents and short-term investments of $30.6 million. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;Now with positive results from both of our two pivotal Phase 3 clinical trials
evaluating OMS302, Omeros is becoming a commercial company,&#148; said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. &#147;We are working to file an NDA in the first quarter of 2013 followed by an MAA in mid-year, and
we look forward to releasing data from two more clinical programs before year-end &#150; our Phase 3 meniscectomy and our Phase 1 PDE10 programs. Our clinical pipeline is expanding, and as many as three additional programs could enter the clinic in
2013. We continue to execute on our strategy of creating multiple opportunities for success.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Third Quarter and Recent Highlights
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Completed a public offering pursuant to which it sold 3,365,854 shares of common stock at a price of $10.25 per share. Omeros&#146; net proceeds from
the transaction were $32.3 million. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reported the completion of enrollment in the first of two planned pivotal Phase 3 clinical trials evaluating OMS103HP in patients undergoing
arthroscopic partial meniscectomy surgery. OMS103HP is a proprietary drug product added to standard irrigation solutions and delivered to the operative site throughout arthroscopy to preemptively block the molecular-signaling and biochemical cascade
caused by surgical trauma and to improve postoperative functional outcomes. Omeros expects to announce data from this Phase 3 trial before year-end. </FONT></P></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Announced the identification of compounds that interact selectively with nine additional orphan G protein-coupled receptors (GPCRs), bringing the total
number of orphans GPCRs unlocked by Omeros to 46, representing over half of the Class&nbsp;A orphan GPCRs and equaling the number of GPCRs targeted by over 30 percent of all currently marketed drugs. These nine orphans are linked to a series of
important indications, including several types of cancer, autism, pain, osteoarthritis, neuropsychiatric disorders, and appetite and body weight. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Began enrolling patients in a Phase 1 dose-ranging clinical trial of OMS824, Omeros&#146; lead compound from its phosphodiesterase 10 (PDE10) program
for schizophrenia and other cognitive disorders. This study will evaluate the drug&#146;s safety, tolerability and pharmacokinetics in healthy subjects, and Omeros expects data before year-end. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Announced that Omeros, its chief executive officer and its former chief financial officer entered into an agreement settling their respective claims. A
description of this settlement agreement and the related lawsuit are included in Omeros&#146; Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November&nbsp;1, 2012. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reported positive data from the second of its two pivotal Phase 3 clinical trials evaluating OMS302 in patients undergoing intraocular lens replacement
surgery. In this second Phase 3 clinical trial comparing OMS302 to placebo, OMS302 met its co-primary endpoints by demonstrating statistically significant (p&lt;0.00001) maintenance of intraoperative mydriasis (pupil dilation) and statistically
significant (p=0.0002) reduction of pain in the early postoperative period. Now with positive data from both trials in the OMS302 Phase 3 clinical program, Omeros is targeting submission of a New Drug Application to the U.S. Food and Drug
Administration in the first quarter of 2013 and of a Marketing Authorization Application to the European Medicines Agency in mid-2013, with a planned market launch in 2014. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>About Omeros Corporation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Omeros is a clinical-stage biopharmaceutical company committed to
discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company&#146;s most clinically advanced product candidates are derived from its proprietary
PharmacoSurgery&#153; platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability,
through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical
programs targeting inflammation, coagulopathies and central nervous system disorders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Forward-Looking Statements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the
&#147;safe harbor&#148; created by those sections. These statements include, but are not limited to, Omeros&#146; expectations regarding when it will submit an NDA and MAA for OMS302; when sales may commence for OMS302; when it will announce the
results from its Phase 3 OMS103HP and Phase 1 PDE10 clinical trials; the number of its programs that will enter the clinic in 2013; and that Omeros may have capability, through its GPCR program, to add a large number of new drug targets and their
corresponding compounds to the market. Forward-looking statements are based on management&#146;s beliefs and assumptions and on information available to management only as of the date of this press release. Omeros&#146; actual results could differ
materially from those anticipated in these </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors described under the heading &#147;Risk Factors&#148; in the Company&#146;s
Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November&nbsp;9, 2012. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company
assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Contact: </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Cook Williams
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cook Williams Communications, Inc. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Investor and Media Relations </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">360.668.3701
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">jennifer@cwcomm.org </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OMEROS CORPORATION </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED STATEMENTS OF OPERATIONS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(In thousands, except share and per share data) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Three Months Ended</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Nine Months Ended</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,417</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">987</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,439</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,381</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,764</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,321</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,568</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,823</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,736</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,830</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,270</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,121</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss on settlement</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,953</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,953</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,453</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,151</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,791</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,944</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss from operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13,036</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6,164</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(29,352</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17,563</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Investment income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(413</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(528</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,360</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,348</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other income, (expense) net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">159</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">171</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13,276</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6,512</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(30,710</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(18,345</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted net loss per common share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1.30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.83</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted-average shares used to compute basic and diluted net loss per common share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,834,730</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,246,430</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,578,724</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,156,883</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OMEROS CORPORATION </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED BALANCE SHEET DATA </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(In thousands) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash and cash equivalents and short-term investments</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,629</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,570</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32,761</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,982</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total notes payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,052</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,446</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,811</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,985</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(206,843</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(176,133</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total shareholders&#146; equity (deficit)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(820</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5,554</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g437857adex99_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g437857adex99_1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`7P")`P$1``(1`0,1`?_$`+4``0`#`0$!`0$!````
M```````("0H'!@(#!`4!`0`#`0`#`0$````````````&!P@%`P0)`0(0```&
M`0,#`P,"`@<)``````$"`P0%!@<`$0@2$PDA%!4B%@HQ05%"88'2(R07&'$R
M4Y,T5)0E-1$``@$#`P,"!`('!04$"P```0(#$00%`!(&(1,',4%1(C(480AQ
M@4)2(S,5D:'!<A:Q8K)3%X*3LR31HD-S@S1T)2<8*/_:``P#`0`"$0,1`#\`
MW\::::::::::::::::::_DD'[**8/922<HLHZ-:.7[]XX.";=HR9HG<.G*Z@
M^A$4$$S',(^@%`1UX+FY@L[:2[NG6.UB1G=F-%55!9F)]@`"2?@->:WMYKN=
M+6V5GN)'"(H%2S,0%4#W))``^.H-<,>7J')F5S-&.P1:.JM<UY.EM.VF@X<X
MNE1]G7EUTRE`RK]J[CU1=F'<2B[2+_#6=/`/G2+R_>9^TF"QRV609[5:`,V/
MD^6!B/=U9&[A]NX@U?/F[PS-XKM<)<QEGBO+$)<M4E5OX_FF53[(5=>V/?8Y
MU/#6DM4!IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIJM;R=9L
M/CS""&-H1X*5KS(]5KXI(B`N4*8R!%6TN/I-UIED.^WCP';ZBNS[>I1VR5^<
M#R$_%O':\2QKD9S/R&`!?J%JM#<M\1OW)"/CW6IZ'6GORK\&7DG/CR;()7#8
M.,3DGZ3<M46X_'91YC\.T*^HU55Q1R8UXN7?%V09=PEME>;6@["@8HF)#X93
MDU8%S83E'I.1Q*W5`';<VVX,X)3;Z7.L7^%.6P^&.08;D]^ZG^NW!AG7VAQ0
MD,)G(Z'=+=CN(:?RK-Z=)=:T\O<8F\N83+<>L48+A;<2PMTK+DS&)A#[C;':
MGMN*]9;M:]8M:?"F*<I3D,4Y#E`Q3%$#%,4P;E,4P;@)1`?0=?80$,*CJ#KY
M7$$&AZ$:^M?NOS3333333333333333333333333333333333333333336;#.
MDY/<TN:S6LU=P!ZR$V;&E/?@H*K1I5:R\7+;;2CVMC;/72KUVD?8.XF")0$1
M)Z?)GR)D,G^8'\PR8G#M7"K.;"VDK55M[=C]U<+3]]S*Z'W';`-5Z?3?@MEC
M_!_@=\KE%(S#0K>W"4HS3SJ/MK=J_N*(E<>Q,A(HW7W7E$K>(J]8\2U^D.VB
M=NIM+3I-E@V96XIMJHQ33=5'Y!1N"8%F$!7="8G3U"@Z(<W2`I@:1?G+Q/",
M;E,'C\`Z+GK&P%I/"H6BVR`-;;RM*2*3)44^B12:?+NX7Y2LGR^_QV8N\TCM
MA;R\^ZAE:O6X8E;C;6M48!.M:;XR!4[J<.QKD7F1G>1K<3!9`O\`)5*@_;82
M@1\XK6:S!U^J%9JF5L#J&!@1RJ6(9F.=5X*JC@0,)A,.^J]X;RCS]Y,NK2TQ
MN4R,N`Q9@[NR;[:WBAM@A)F:+9N;M*26EWE^I8GKJ<<OX[X.\=6MU<Y'&V*9
MS)"?MAH?N)Y9;C<`(EDW!5[C``1[0G0`#IK2/1,K8SR>U4>XZOU1NS=$A5'!
MJS/QDPHU(<0`AG:#)RJNU`XCZ=PI=]?6#CG,^(\PA-QQ7)V.1B45;[>:.4J#
MZ;@C$K7_`'@-?,[/\2Y1Q680<EQ]Y82L:`3PR1;B/7:74!O^R3KW^I-J/:::
M::::::::::::::::::::::::::::::::::C'S%R>.)N.V1[&T>G93LE#J5.K
MJ(&*#T;%:0-#QYH\ACD%1ZT!P=P0`'Z>R)A]"CJH_.O+CPKQ9ELM#(8\C);F
MVMRM-_W%Q_"CV`D5=2Q<?#:3Z`ZL[PWQ?_5ODC%XN6,26"7`GG#?0((/XLF\
M]:(0NP_$L!ZD:KNX"8XC,/8KRKR<F6H.E:K3+%$PQ>VD5-Z>LMG4M9W2:_6*
MC@5I)LE')+=8$,1%00VZO3+WY:.)V7`>%9CRU?+O>SL)XX^@`<VX:2X8&I+5
MD40J]:$*QZ5Z:+_,)RB\YQS#%^,K)@J75]#(_4DKWRL<"D4`6D;&9DI4%P/;
MK!O">$KES'SW+HV297;C*IV.VW:R$`[IQ%EZ2BSZB+_2+E[+R+9NFD(_0D4^
MP=*0!K.?`/'6>\]^3)_ZU.RK,L]Q=3"K-'T&RN[IN:21$"^RANE$IJ^^;<^P
MOA+QY`F&A5WB:&"VB/RK)U._TZA5C1V+=:L5ZU>NNA\$[I,XAY`7;C]=7*D"
MTRJUL.))]%<#'0A\A1/RC"O2`-S'3*J95RHZ9)[F+W?>)>NVPZ[_`.6W/Y#@
MGE'(^+N0N;:'-)/C9@:D17T7<2!Z5%:DR1+U&[NIUI37'_,%A+'FOC>P\D8%
M1<2XEH<A$1ZR6<O;>9*T--H$<IZ';VWZ5KK_`%<K<$.0G$5-',^*[S]U,:6`
M/WECJ+1Y7[=76+4I!7D):O*.9)M+5T"`/O")N'"8(`85T>R!C![O-?RV>4?!
M@7R!PG)?>V^/^=Y[9&AN8$6FYY("TBRP4_F@.XV5,D>P$CU.(_F"\<>9F;@W
M,<>+.>^^18;AEFMYG:M$CFVHT4U?Y1*(=U`DF\@&Z_BGG`.0V#J=DI=!NSG'
MB+J'M;)H!@:M;1!N#,);VA3B8Q&;TZ972!1$PD17(41$0$=?0GPMY%'E+QU8
M<ND58\C(K17*+]*W$+%)=OK1&($B`DD(Z@DD:POY;X&WC?GM]Q9&9[&-ED@=
MOJ:"50\>ZG[2@['-`"RD@`:D5JU-5MIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
MIIIJH3F:-QY(\C\:<<,="`1U$,I8+C/*)F6B8"S2[%)9*0?&2!1,[RI510SE
ML@<2"L[>E3'TWUA_SRF?\L>5<1XKXL:66-K/=3$$QPW$B`AWI4%[:V)>-#0O
M+,$UK[PO)@_&7C?*>2.2"M[D`(+6$$"2:!&.Y%K0A+BX`21Q79'$7^&K"Y_#
M=?9\?;%A&G1J3"$-CF=J$(Q*.P&6=Q+M%)5RJ81,JX?2"PJKJ&$3***&,/J.
MM/Y+@N,@\:77C_!1+%COZ7+;1)[5:-@"Q]R[G<['JS,Q/4ZSO8<RR4O/[?G&
M8E:3(_U&.YE?W^612=H]@JC:BCHH``Z#5?OC>KKZNWW+J4PV(SDEZQ3VYF:Q
M]Y!HXBWTNUF4W27;(9$3/CE*&XB)^UU?IMK-?Y5\/=8CD.;2_01W36EJI0D=
MQ6C:59=PH*5>@ZU)VUU??YC,Q:Y7!X@V3F2V6ZN6#`'8RR+&T>TD]:)UZ4`W
M4]M=(SYXY(3,F97^9Z[E22QG-R2D#)N64;4FDR0MH@2HIH61L[/.Q)T'2Y63
M8QR=!MUD14ZA$X@$@\F?E2QO/N?2>0,9F9L1DI3#(RQVR2C[B"@6=6,L9#$)
M&2*'YE+5JQIS?'OYF,CPGA"<&R.)ARF/C$R!I+AHSV)JEH&412`J"\E#4?*V
MVE%&K$7'MVE>7^Z7;!TT:PROW$_=MTF<6X;HL3?+NW+595=!JP52*H<Z9CG(
M1,1`3"`;ZU-)VH,6W]8DC>%+<]]V`6-E"?Q6922%0C<2"2`O0DCKK-D?<FR"
M_P!+2196F'9526<$M_#56`!9P:`$`$GJ`-1'X#8T=XRX\QC9TS<1I+E;;AD"
M+BG:9T7496K)*F^TFSE%0`40<*U9DS6.F8`,F942F`#`(:H_\M'$)N'^+889
MD:);^^NKV.-@0T<%Q*?ME8'J";=8F(/52U#U!U<7Y@^4Q<J\CRS1.LK65G;6
MDDBFJR3P1C[AE(Z$"=I5!'0A01T(U-'5_P"J1TTTTTTTTTTTTTTTTTTTTTTT
MTTTTTTTU_!*/R149(2:B#AR2/9.GIFS-(5W;D&J!UQ;M40]5G*W1TID#U,<0
M#]]>"ZN!:6TETRLXC1FVJ*LVT$T4>[&E`/<]->:WA-Q.D`95+N%JQHHJ:58^
MP'J3[#7%,`XK<X\KDQ-60YW>1,E6&2O]]=*J`L#*:GU/<EK<>8#G3)%UEJ8C
M-/M[$5,F=78.O8(#XWXA-QC%3WN58OR;*W3WEXQ-0DLQW=A/4".!:1K3HQ#/
M0;J"9<\Y/#R')0VV.4)@,;;):6H`H6BB%.\_N9)FK(U>J@A*G;4_>9.26),`
MJ0X95FI>MMI\%0B9-.IVF8AW;A`1%9A\K"1$@P0DB)AW/;J*$6,G]92B4!$/
MXY[Y8X1XR,!YI<S6D-S7MR?;7$L3,/5.Y%$Z+)3YMC$,5^8`@&GFX5XRYCY#
M[XXC;Q74UO0R)]Q!'(JGT?MRR(Y2O3>H*@]"02*P%E>6O%2N9&5R[BS+C!&4
MD4U4+31YBFWZ-C[&BZ5*H_<1\PWK)_C9%95,JX%<I+MQ<$ZBF1ZU>YG*Z\[^
M$L7R9N9<4SL2W<H(GM9+6\C68,07*2K;G8Y(#@2*Z;Q53'N?=>L'A+S#?X%>
M+\BPLIMXR##<)<VCM$0"%#1F?YD`)4F-D;::$2;5VSJP-R@Q-R,3G"XWEGKV
M0J[>)6L3![%OV(QWS(OBL@3=.6Z35\10\<L&Z1A$`*`F`NX!K0GC?S#P;RJ+
ME>(W+S7-FL9G1HY$V=W>$HS*%>IC;Z2:4Z@5&J1Y]XKYGXV-NW*K988+MI!"
MRR1OO[>W=T5BRT#K]0'KTK0ZKD\H62LS5._8TK..+/=XJ`GJ1,/)R$K"3MQ'
MR[QI/H@D:2;-F;HKOMMR;&3/N0R>X&*)1$!RC^<7EOD'"<EQ&'XC>9&'&W./
ME::*W5F25EF%.XJHVZBCJIZ%:@@@G6FORI\7X+F./Y7*\JM;"6_M[Z)8I9V5
M6C5HFKL9G7;5O1AU#4H00-1DP7/<Y<Y3A(:-SWD^`%%1NLY^7+8B'*R7%P;W
M(G;U]4B1`,V$`[IBDZ1#81_W=5-XSO?S'>2,@+*#D^7M%5E+=T3`A&W'=40$
M#Z3]72A'7VU97D:W\!^/K'[F7CF+NF8$+VC$1N&WIUF!/U"NWK4$$>^KU\+4
M&Y4*KM8Z[7ZP7Z8%(BCJ4L,HXE'AW2Q$U7']Z=M'HHH(K&.FDD1N7I3`HF,8
MVXZ^D'`^-YKC6&2SSF2N\G?4JTMQ(9'+'JW7:@`!J%4(/E`J2:G6`N89[&<@
MRSWN*L+;'V9)"Q0)L0*#0=-SDDBA9BQJQ-`!379M3C43TTTTTTTTTTTTTTTT
MTTTTTTTTTTTTTTTTTUXS(&/:;E*I2]'OL"QLE8FT!0?1K]/J+U!]2#MJL02K
ML9!FKLH@X1,19%0`,0P"&N#R;C&!YEA)^.\EMH[O#W"T>-Q4?@RGU1U/5'4A
ME8`J0==KCW(LUQ3+PY[CUQ):Y6!JI(AH?Q5AZ,C#HR,"K`D,"-5/2'A[J2K]
MZK%YSL[&-4=+J1[)Y3(F2=LV9U#&;-7,B2:8%?+()"!3+`@EW!#JZ"[[:Q+=
M?D0P+W,CV?([V.T+DHC6L4C(A/RJS]U-Y4="VQ=WK0:U_;?G2S:6\:7>!M)+
MH(`[K<R(K,!\S!.V^P$]0NYJ>E3J7?$7AG'\4'E\=L<@R%X&\-ZZW43?5YI!
M!&A7U)E0ATS-I.1%R+KY<0$!`G1VPVWW]+S\&^`;3PG/DI[;*2Y$Y%8%(>!8
M>WV3*13;(^[=W?>E*>]=4WYD\WW7E^#'PW&-BL!8-,04F:7?WA&.NY$V[>W[
M5K7VIJ;.M"ZHK3333333333333333333333333334&K]Y+."N,[I=<>6SDG0
M273&]:FK?D"!KH3MV<TNOUU5HC.N[,K2H:PM(9S%+/DBK-%U"/"&-MVO0VTH
MM.%\IOK:*\M[*;[:9PD;-M0.S5VA=Y4L#0T(Z?CJ(7G/>(6%W+8W%_#]W"I:
M14W2%`M-V[MJP!%152=PKZ:D7A?/&&>1=):9'P7DRG94I#U91JG8:9-M)AHW
M>HE(=>-DDT#^ZB)5N10HJ-'2:+E,#%$Q``0WX^3Q62PUT;+*P26]T!7:ZE33
MV(KT(/L14'XZ[F)S.*SMH+[#W$5S:$TW(P8`CU5AZJP]U8`CW&OC-V>L.<;J
M*ODW.N0J[C&@MI2,A5[5:'*C2)2E9E8R$6Q.LDBN8%WJQ!*0.G81#]=,9BLC
MF;H66+A>>[*DA5%30>I_5K]RN7QF$M#?9:9(+0,!O<T%3Z#^XZ]U4+?5<@5>
M`N]'L4-;J?:HEE.UJSUV1:R\'.PTD@1RQDXN29*K-7K-T@<#$.0PE$!UZMQ;
MSVD[VMTC1W,;%65@0RD=""#U!&O:M;JVOK9+RSD26UE4,CJ0RLIZ@@CH0=<>
MS[RPXW<6FE:?<A\ST/$#6Y.9-I55+K,I19I]Q#(M7$LG&)"519R$<D^0%8Q2
M]*?>(`B`G*`]'$X#-9UG3#VTMPT8!;8M=M:TK\*T-/C0_#7+S7)<#QU8WSEU
M#;+*3LWFF[;3=0=2:;A7X5'QUWUJZ;OFK9ZT5*NU>((NFRY-^A9NX3*JBJ3<
M`'I43.`A_0.N2P*DJW1@==I65U#J:J14'\#J(/(_R`\.>),M&UO/^>J?1K=,
M)(N(RD)$F;9>W;=R.S5T6E4N+L5H1:/#`((K*-")+"`@0QA`=I%A>(\DY#&T
MV(M));=:U?Y4C!'J-[E4J/<5J/?46Y!S?BG%W$6<O8H;A@"$`:22AZ`]N-7<
M`GH"5`)]->QXY\PN-'+6,GI/CQEZKY*^U5F;>UQ$?\E$VJJ+2`+BP)9Z=8V$
M-:Z^#_VBP(&=LTB+"D<"";H-MZV9X[F^/R+'F+>2`R`[2:%7I2NUU)1J5%:,
M:5%?77MX#E7'^3Q--@KJ.X"4W`55UJ2!N1PKK4JP!*@$@@>AUY',7D!X7<?;
MV\QAFKDCC#&N06$=&RSNHVF<%C-(QLP@9S%O!:=A0QD7R!!,F)1'J`!U[.-X
MCR;,6HO<793SVA8@.BU6H]17\->KE^;\3P-T;',7]O;W8`)5R00"`1[>X(_M
MUZ+!/-?B3R<D7T+@'D1BC*L]&M3/WU=J=OC'MC;L"'!-20/7E%4)H6"*@@4Z
MX("D0Q@`Q@$0`?!E>,\@P:"7+6=Q;PL:!G0A2?AN^FOX5KKV</RSC6?E:##7
MUM<7"BI17&\#X[#1J?C2FI0:X>I#J)V5>=/$?">3:[A;).=J3!Y<M3ANUA<:
MLUY"S74ZKM`[IJ:1KU5834C`MW+4@JIK/R-DCIAU`80V'7?L.+<@R=B^2LK6
M5\?&"6D-%3IT-&<J&(/J%J=1K)<QXSB+],5?WD29*0@"(5=_F]-RH&*U]BU`
M=>AXY<ON,O+B`?67CAFBD98C8DZ2<RA79!5*=@C.`$6WS]6EF\;9X(KKI'M&
M=LT2JB4P$$1*;;PYGCV;X_*(,S;2V[M].X?*WQVL*JU/>A-->?!<GP')86GP
M5U%<HGU!20RU]-R,`ZU]MRBOMJ2&N-KO:A+-^1GA;"9S@.-1<\5FR9NL-B:5
M9*AT./LF0WD--/'!6A&UODZ1"S\%2RMW9RI.3RKIF5J<X=X2!N(2>+AO)I<4
M^;^TD3%HA?N2%8P5'6J!V5GZ>FP-7VKJ(3\\XE!F(\!][')EY)`@CC#RD-T%
M':-66.A(W;V7;45IKMF3N16(L.S];K.0+0,-,6GI4CT$XJ6D4FS,ZCA%.1EG
M,<R<MXE@HJS6`JBYB=16ZR@`*:"YT^598F_R$3S6J;HT]>H'7X`$@D]1Z?$#
MU(KV,AG<7BYX[>]DV2R>@H30>E6(!H.A]?@3Z*2.T^X0_P",E_S"?VM<ZAUU
MMP^(U1AY^^;]KXB<0&%0QA.NZUE;D=8)#'T-9(U<[68JU&B8P)/(UBA':1RK
M,I@S)VSBV[@FRK8TJ*Z1B*I$,%J^(N*V_).2&XOT#XZR02,I%59R:1JP]Q4,
MQ'H=E"""=4OYQYG=<4XH+7&N4RE^YB5@:,D8`,C*?6O54J*$!RP(8`Z[/X;.
M'M`XW\!,-E/4856_YWH<3E?+\Z_BV;J7LSS)$<G/QU?F73E%5PZAJY6))M'I
M,SF,W`R:RO1W%UC'Y?DGD=WFN77)[C?:6DS10J"0J",[2R@>A9@6)]?05H!3
ML^)^+66!X1:5C4WM[`LT[,`6?NC<JL?W40A=OI6II5C6B:"L0^)3SRO<38\6
M4K/&'E)8J`UEZ"BH=O6(V#S886->?,8\!,T9!C3+1G24>J0O6WA!6:`()J"&
MK7E@_P"H?B49*\&_/8])*2?M$P]6!/J>Y#0L/=Z-[#5*PW1\7>;#B;$]OC>3
MDC!B'TJL_12!Z*(IBVT@=(U913<QU;A^17&NY?QM3T?'HJ.G[S-V$6C%HB7K
M6>/7UL]@T:(AN&ZJ[AT4I?XB(!JN_#4B1<WCDD-$%M,2?@`E2?[!JT_/44D_
MCV6*(%I&N8@`/4DEA37"OQG^0;N\<3\G\<+&\<&LG&[)KDT3'O51]RPH63/?
M3;!@F@J/>33C+Q%3Y#E`.E+NIE]/0-=?SCAUM.109J`#[>^@%2/0R1T4G]:&
M/]-"=<'\NN?DON*W&`N2?NL?<=%/J(Y:L!UZU[BRD_YAJD#\AK.\IF[GK+U2
M..X=8YXVP]<PLQ>H]9HK_,6;9(Y!OY"'$12^73^5:,7!2AN`110-^VK4\,XJ
M+%\2%P]!?7S-,1^UVU/;C_[/0L/\^J9\_P"9GS'-3:Q[CC<>J0`_L]QAW)*'
M]ZK;&_\`=C6U?E%R!8\3N&N5.0;UNF_-B?#Z]@B(]QOV):S_`!;6+J$2Y$AB
M'*A+VE\S;*"40$"JB(>NLO8'$/R#D=OAT)'W%P%)'J%J2Y'Z$#']6MB<CSB<
M9XG<YU@";:UW*#Z%Z!8U/X,Y4'].J"OQS<)FS,?DEY%<ZF#).=+_`)7D:'7;
MS:DDI25AQ81$19;W-P9W1%2Q3F<?65I')&;@F+./C`:(=M`ZB9K=\T9,8LV7
M"\5_`Q,%N)&1.@:I*H&^.T*S=?5FW&I`.J.\`8HYD9#GV:K<9F>Z,:2249EH
MJN[+\"V]5Z4H%*K121K3ZRHE*C;?,7^.J==87BQ1,;`V"W,H=@UL4["PSAX[
MB(N8ET$$WTFRBG,@X.V37.<J!EU.CIZS;T4UU<O;K:/(YM48LJ$DJK-0$A?0
M$@"I'K05]-:.2RLX[I[Z.*-;R1`K.%`=E4DJ&:E2`2:`^E33UUDRY:-DA_)I
MXN`H4JR;N)Q,=1)5,IT]@H62D.@2F`Q3E$$0'U#]1UH+CY/_`$-OZ>HDD_XX
M]9DY.H/YA\:#U!2+_@(USGS2TV&XB^53A+R#XX1#&@Y'R&ZJ]@L\93FB<2WL
M=EA,EQM3>/GD7&E1064R#5I\T3*$*F!9%)$PJ@=0ZAC>_P",KJ3D7`,KALVQ
MELH0RH7-=BM&6`!/_+9=Z_ND].@`'-\NV<7%O)>'SW'U$&0G*,ZQC:'99"I)
M`]>XIV./V@#7JS5T:>4KEZ^X0\)\N9OKHM1R$#6.HN+$WB)'#8N0[N[+#0DD
MNV5_NG:-9;'<RQT3@)%R,!3-Z&'5,<#XXO*>46V*FK]F27EIZ]M!5A7VW&B5
M]MU=7YY)Y6_#>'W69@I]\`(X:T/\1^@:AZ'8-TE/?;3WU6W^.QQMB&'&6R<T
M\A-E+EGWDYD*\23O)=K_`/=6[[+KE@>5OVR,U(%7D$5;);8R3D)!4BA1>BHW
M*IU%;I`6:^9<U(V>3C%F>UB+"&,").B;V4-6@Z?*A15'[/6GJ=5]X$P4?^FW
MYAD/XV;R,\A,K_,XC5BI4,:GYI`[,:_/\NZNT'5>WEQ3=^+7RC<>N<''YB%/
M@LS1#B9RK3X`A8JNW5S4K!%1678-]&,BHL3-KU3IN-=*%$@B2;2&0+_B-CA,
M?'>WGO`[WBN7/<FM6`A=NK1AU)B8$]:HZL/\GR?3J">4R_C7R3C^88,=J&\%
M9HTZ+(48+,I`HM)$9">G\PF3Z@"+L?-)R5N6(/&/DO*.$9][%2N24\<T^$NT
M*LLUD82IY2F(UO)SL0]0$JS!\^K#E5LW<D,51LH\*JF8JA""%7^,L';9+G,&
M/RB!HX3([(WHSQ`T4CW`8`D>A"T/0G5P^7>0W>*\<W.3PTA66=8T605!5)2*
MLI%""R54$$%2U1U`UY[P(XAPG1?'3A:_XSAH!6ZY796"P9>NC9!JO9YNZM+9
M.13Z!FY38[\C.IECR,VK(QBHI$3%8"=Q=113S>6LCE+OFEU:7S.+:W95AC-=
MJH44@J/2KUW%O4UI6@`'A\)XS#VG`K2^QP1KJY#M-)T+LXD9=K'UH@`"KZ#Z
MJ58DV499XT8LS18Z]:;NPEEI2O((LBC&2R\>A*1C=VY=HQLD0A%%"))C(/$>
M^T.U>"T?NVPK"W<K)'@]CF;['0O!;%0CFO45H:`5']@-#45532H!U8.3X_C<
MM<)<W:L9$`'1J;@"2`?[6%5HU&9:[6(/=?8LO^S:_P#CI?V-<S<WQ.NSL3X#
M^S6,[\K!61'(/#M!0ROQ):!FU5J4=^S\D>:QZ1Z8OKMW?:D;[^GZ;:TMX`"?
M9Y,C^9W(:_HVR4_OKK(_YF2_]2PH/\O9-3].Z+=_=MUKAP&V;,\%86:,RD(T
M:XEQRV:D3VZ"-D*=#)(%)T^G05(H`&WIMK.V59FRERS?4;B0G].\ZU-A%1,+
M9I']`M8@/T"-::QC_D)KJ+^5GC>A7]S6%MBO`:28-@_Q'RRV;[XM$$`2?4*P
MB=,2?OZAK3/AT`>/K\S?R3<3^OP[$=?\=9#\[$GRGCEM_P#Y@6D%*>M>]-3_
M`&C5^7GB4,EP;@U2#L=/E+Q>.0?X&+E:&,4?ZA#50>*A7E+`^GV-S_X1U?7F
M,TX@"/47L'_$=4YX=M#;QA>>[D=2)5NNPP_R)K>1+7%1[%NH+=PQN<$]SK36
MT,T*4PK.F%[K\I6&12`8>XY$@;]6K+R4#<Z\1V5U&0<E8R1H2?6J,(&W'X&-
MEE:OPKJH,3<CQQYNR%G*&&)R$<LB@>E'7[A-H]:B1>P@'Q(U7)STQQ883@)P
MES[?D#)Y1YM<C>4W+2^*KE.+KM9*#'ZE'9=Y7^].P1I;=JZ;E'Z2>^/M^NIG
MPZ]AEY?E,3:'_P`AB[&VM(__`(7<W]/CO)!/OM&H'S['SV_!\3F;T?\`W'+9
M"[O).I/\PP[*$_LE`)%'H.X=:B_/&O(H^)'+@1XJ`FNYP,A)]OJ_^8?*-$,J
M"G2`[I"X(D`[[!JB?$8C/D2UW^H$]/T]J3_"NM%^;FD7Q3=]OT/VU?T=Z/\`
MQIJN[PN+^0U'@!1@X5Q_#MY3C91S&:]GY&/,NMK06Z?<3$K<D(3'*1XPT)]M
M@T$1<#[CO;_R=.IEY.'#3S";_4[9,7/8AV?;"$KLVGZN[UW;J^G2GXZ@GB,\
M^'!+<<.&)-KWY>Y]V9]_<^7Z>UTV[=OKUK7VIK0?Q05YUJI7_P#UM-.,C5R5
MY7O\L_\`38OD==D=@9"6&S_=PY%*5T5VFY]D#/VP=`D[HG]>G5/9\<5!B_TN
M;\K1NY]R(@:]-NSM=*4W5K^%-7OQ@\U*S?ZQ&.$E5[7VAE(I\V_?W>M?IVT_
M&OMK.1R^]P'Y,'%L6@(F>!7,7BS*Y,=-L=X%#RF+4CE1(BJJ;8[CI!0Q2F,4
M@B(%$0`!N?CU/^AU_N^GNR5_1OBKJA.4[O\`]A<;MIO[4=*^E=C4K^%?77Z\
M&I%+R;^7#*F2^<[4:/G/A8U8-<-\8(4A5:'$&QQ=)F'FI&2G913YJR2E"OLB
MVE3%*@@G(NY!NX^AHU(UU^<JC;@_CNWLN*GNXG*$F:Z/UMW$4J`HZ*)(P5]3
MM"D?4Q;7YPV6/R+Y2NK_`)BO9S.'`%O:#Z%[4C!B6)JQBE*M4`;G:H(1=FI0
M?E!*R9.$6&$FPJA%K<GZW\J!=^V91/&643QP*[#L(`MUB7?^8-<7P.(SRNY+
M?S!8-3_O8JZ[GYEC,.%V@2O:.23=_P!S-35A_A<;MFWBZX<IM>GMGQM(N3].
MVWNGEWM;Q[OM_-[Q=3J_???4+\F,S<[R1;U[X'Z@B`?W:L7Q*B)XZQ:Q_3V&
M/ZS+(3_>3JE/\K-RQ^W^$[,PI_(?*Y_=;;AW0CPC,4HJ"(;;]LS@Q?Z-PU:/
MY?E?OY1__9[+<?KK+_AJFOS.,G9PR#^=ON"/C3_R_P#CJ]"F<<*KRV\6F&^.
MV9".R1.3.(V$(:9D&A2#,5^P-<<T^4A+-&^X**835:L;!L]2!0.@ZR'0H`D,
M8!JBZS5QQ[GESF<81W(,C.R@^C*9'!4_[K*2I_`].NKILN/VW*?&EG@,N#VK
MC%6RL>FY7$4;*XKTW(X#`'H2*'I765[CMR!Y5_C^<LY/CKR*CGMPXNY`G"3L
MH$4FY<0$_7%W"40GG3#BRXC[*R1C-)(D]!*&`[@J`-EP*L5F[U?F:P^`\P<>
M7-X5A%R"%-M#3<&`KV)OBI->W)[5J.FY=9JX]G.2^"N4MQWD"M-QFXDW54$J
MRGY1/#\'``#H>IIM:E$9=U$!.P]I@H6S5Z1:S$!8HF.G8.68J`LRE(>79HR$
M9(M%0V!5J]9."*IF_F(8!UE.6*2"5H)E*S(Q5@?4$&A!_$'IK:,$\5S`ES;L
M'@D0,K#T96%01^!!!&O];7CUY=9Z_P`C'AU:^1O$:L9>QW!O;'<N,=BFK5+P
MD6U.\E)#%5LC&T?D!PP:H%,Y=KUQQ#QDHHF4#"#%FZ,`"(``W%X8Y+;X3D;X
MZ]8):WZ!`Q-`)5),=?P;<RC_`'F75$>?>)7?(.+197'(9+[&R-(5`JQA<#N$
M?Y2B,?@@<^VIJ^)KEWC_`)+\`L)W1&VP1;%BK'$!CC,C-S*-&SBH67'$&A!/
M9.P@X63"-C;!$1*<PV<*""!VCH#`?<B@%B_D'CMY@^775JT;=F>=I(2`2'21
MBP"_$J3L('6H_1J8^,.46/(.#V=T)4^XM;=89P2`8WB7:2X)^4,JAQ7I0_$&
ME`F***Y\MWG+M_)2I,G$SQ.XPW.F.!OO865K-C1PTS02Q]!0[Q8B:#U?(>1&
M:\V1`/J+!=Q4X%$Z0'MW(7:^//%4>#N"$Y%?QO6/]I>\3W&8>W;C(2O_`#*`
M>AI1N-L'\H^9I.16RE^+8V5"):?(W8`$:J?VN[(N\#_EEJ]10W)>>I3HX-5\
MNV_>Y3\8D]]]NG;)T:MO^@[^J6W]>JS\4"O*F_\`H;G_`,(ZN'S*:</7\;V#
M_:=0^\[_`!&N^1N1WCASSA]$S/($GGNF\=)"=3;BL2,<2UJ;7_',U(D*)0/&
M5Y6*L2KCK$"F25Z!'8=27Q1R*ULL+F\1DNMF+-[@+6E=J]N0#\6K&!^C4-\U
M<5NLAR#C^;Q8VWS7R6I:E:%F[D)/^ZA$K&NN`?E$PT)4\8\"*S7HUE"P%<L&
M6H:!A(U`C5A%0D)6L7Q\=&Q[5,`3;,H]DBDBD0H`4A"E`/0-=GP-)+/D,M/,
MQ:5XXBS'J2S-*22?<DU)UP?S)Q0VN*PMM`JI!&\RJH%`%58``![`"@`]M:(N
M7/'9'ESPERSQ[%P@P?91Q$6,KCYW_P!-&W%@S86"DOW@@4QBM&5LBF2BPE#J
M[13;>NJ9XYF3QWDUMF:$K;W%6`]2A)5P/Q*%@/QU??*<`O*.'W6"J`]Q:T0G
MT$B@/&3^`=5)_"NJ'OQO\XEQ:QY'^/?-*9L<YRQ[E>4OT'0K68D5.2!7\1$5
MF_P,8V=&3%^_J\M5V[TZ:/6*[.3*Y2ZT2G4+;/FO&?U"2RYCC/XV*GMQ&TB=
M5!!+(21Z!@Y'7T*T-#0:I3\OV6.*BO\`@>8K!F;>Z:18Y**S`JJ2*HKU*%%)
M`K4,2*A21J":W.HO;5*45E9X!Y=(.)CYZ:JC668N+%#PDNX=-8F5E8=%<[^.
MCY1RQ7(V563(1<R"@$$W0;:B6MKA8%NF1Q;,Q57(.TL*$@-Z$@$5`]*BOKK1
MZW=J]RUDDB&[10S(&!958D!BM:@$@@$CK0T]-9+N62Y3_DV<62"'3V(O$B(B
M8P;&,>AY)5+M^FV_?`H!^X_[=:#X^/\`\&Y#_/)_QQZS%R8__P!#XW\$B'_J
M'_TZ^?+5%2OC;\J7&/R4T2-<I4#++Y*)S)'Q9`32DY6O1[6IY)CE4DB@C[NY
MXFDF[MF"@"*LM$JN!W.41U^^/)(^:\!O^$73#[RW&Z`GV#$O&?C1)00U/1'"
M^FO'Y1CE\?\`DO&^0K)6^QNF"SA:T+*!'(#UI62%AL!'UAG/4:NG\K7&E7GY
MX\+U6,0J-K=:%8JI9TPDI'+)J-K?*UU$M@BF,4N;I34/=J=)/&+(XB4@K/DA
M,(%W'59>/\X.(<RAN,B#'`&>">OJ@;Y23_D<*S?@I]]6]Y-XZ><\"GM<61+<
M%$N+<CJ'*C<`OIUDC9E3J!5A7IJ('XZ?)ZLY#X8)\9)J50BLQ<8[9<JY+T:6
M-\=:/LBP6B4M$)-_#O.R_%M%R\T^AW8=L3,G+$"+`054@-)/,V#FL^3G.Q+N
MQE_&CJXZIO5`K+4=*D*KCXANE:&D5\!\AAO>(#CEPVW+XZ616C;H^QW+AMOK
M0,S(?AM%?J%:VO)E%/?+EY9,/<1,#.QM>-./5>1K^9<AP"A)*L4]*8LC><S)
M-&EVXFC@5AX9A&P;4O<W<V`AFI1$2F$LUX-*GCOQ[<\CRH[=]>O6&-NC/M4K
M"-OK0L6<FG2,[M5]Y%@D\I^3[/B^%/<QN/4+/*O58R6W3L&'3Y5V(!7K*NSW
M&MD<-$1U?B(J!AVB3"(A(UC$13%`.E%E'1K5)FQ:(E]>E)NV1*0H?L`:S9)(
M\TC2R&LC,23\234G]9UK***.")8(@%B10J@>P`H!^H:R\_DE6.D9C@>+?$'&
M<6ADWE[9,RISU1HU5*E+W"O5&5JLQ!/F\H@U%1>%9W29?1JA".!2340BU71]
MDFHJ!>WA**YQD]_R.^;L<=CM2KN_1&<,K"E?J*`,.E2"X4=6UG#\P<MIF(,;
MQ7'K]QRB2\#)&GS2+&492#^[W&V$`T!$9;T6NM%?&G&4GA;CK@?#\T^))S.+
M<.XUQ[+R*2AE4'LI3J=#U^0<MU#@!S-E7;`XI;@`]L0U36;ODR>9N\E$-L=Q
M<RR`?`.[,`?QH>NKZX[C9,/Q^QQ,S;I;6TAB8_%HXU4D?@2.GX:[;KEZ[.OD
MW3TFZ^GHZ1ZNK;IZ=OJZM_3IV_7?335$>1>,7X_V1;S<[?9[=PPB;,1VY6R;
M'TOEA!XSA'#A-VH#Y.^4RA9<K-;3#Y`JGN"NF:?4OU]S<XCJUK/.>7+*TCMX
M(\FUO3^&7M#*?3IVWDA9O2E*-Z>G35,9#CGA'(7KW=U+BDN0Q[@CO1"I.[KO
MCBG1/J]:J/F]>NK6>+T;Q>A\/P,5P]4PRM@^/</6D$K@B5JD[0E)%$R9)0Q)
MBG/)",DYH5`)[M91=5TH?853";UU`<Z^=DR+R<C^Y_JA`+=\.LE/;HX!"_`4
M`IZ:LOCT?'8L8L?%_M#B58@?;E&CW?M?,A(+5^HDEJ^NORY/P'%ZQXW91_+E
M?%+?%:=XIKU@IF.R0E5J(Y`9RQ%:*1"2GY6'8*V$\T!08-P5%5=?8I"''TTP
MDN;AO2_'Q.;_`+;@]E69]A'S]%!.VGU&G0:_K/0X&>Q"<C-N,?W`?XS*B;P#
M3JQ45I6@KU%==?M"=*45J_WD-;!9.UQRE-^XE8Y)0;J5I(A%!70D#D,K9/8F
M=]@K?=P*7=Z0Z0-KG0&YH_VV^G;._;7Z*BNZG[-:5KTK371N1:$Q_=]NO=';
MW4_F4--M?VZ;J4ZTKJ'W-VE>.VY,<<$\@#SC:SCV#NTFQ:/(F_U*B-U'KI"#
M+;_M)2U62O%DG!6R,?[P$!5,B441-T]9=Y'QBYYC;O,>)"]+D+W?MT=^@W;-
M^Q6I^U2M*]=1CEEIPBZ6`<S-@%7?VON9$C]=G<V;V6OHFZE:?+7U&IOQI&*4
M<P2BQ0&,39-21PM5`6;"Q(@F5H+=4ICE50%N!>@P&$#%V'<=1=]Q<EZ[ZFM?
M6OOJ6QA!&HBIVZ"E/2E.E/PIJK[F?AOQ)9@R=$QO,B=XO0.>&C*,^%=6C.%>
MPKG`(]0HC""E(0M[I5]D60)%$&0+&62(41[(!ZZG7&<EY"QUDTG&DOGQ1)W!
M8&F@K^UT:-XP?WJ4/QU77+L3XQRUZ(N6/CDRP"T+W"V\]/V*E9(Y"/W:U'[N
MNK<),:^._%A\C5O@Y*8'E[`56!6S"\QIE6)R]D-1;:2)6AR99UK=<KJ!#&!Z
M+%*2=%2`W?%$H#W-<_D][S&_[,_*5NUB^;LB6(PQ^V[M)L1/W=Q45^FOMKI<
M/Q_!,:)K?AK63R_+WC%,)Y?5MO=<O))2N_:&-*[J=:Z_*]47QM/>8]0MN1'W
M&0G.=JI6C4AK9,B5%AGLRC:*?)50(&E.[.VLSP30YW`M`28'!5'K,4#``B"U
MNN9KQV2"S%]_I<[MY6-S!U/S;G"[1U]:MT.O)=V?!GY-'<WIL/\`58*[`TJ"
M>H`V;8RX8]*4^7KTUT7F76>%%KQE"QG.US@AKB<ETCG=?5Y`VVKTRIC?$8F;
M)&$B9>TS,$T/81A%9#MH)+BJ=L"P](D*80]/C<W)H+UWXJ+LW_:(;[=7=^WN
M6M0@8[=VWJ12M/?7N<JM^)7-@D?,39C'=X%/N72-.YM:FUG91NV;^@-=N[I0
M'78L&P^'X#$./(?C^M4E\)L:O')8P6H4XWLM*/3C)BK#C5)QG(2K*1KX-U`!
MH=!PJ@"/25,0(!0#G923(RY":3+=P9,R'N]Q2K[_`'WJ0"&KZU`-?7KKJXF+
M&0XV&+#&,XH(.UVV#)L]MC`D%?A0D4].FJR>3.`?"IE_-5A><@K+Q-@>0S%5
MPG=?9\CH/"^5U%B-P%\%YC:5DJEV!^[,T,7OJ2:*BXI`4#&Z0`-3C!Y?R;CL
M8BX=,@V'(^2ML9HJ5Z;#)$Z@5]-A`K^.JZY'@_$66R;MGI,8F95OXE+M;>7=
M3KW!'-&Q.WUW@FGKTU+?A)4^`U(H4Y6^`KOCL]I$?)-2VYS@*Z5'((J3)T5C
M,1N]KK\]99B3E@;=SL#*/%5BI=0$V+OJ/<GN.675VL_+1>"Z93L%PCQ_+[[$
M95`%?7:`*^NI5Q*UX79V;V_##8FU5AW#;R)*=U/E[CJSL33TWL33TZ:F6^3:
MK,GB3X2`R5:N$W@J*B@F#4Z1RN!.L4Z8HD!$1W,!BB4/7<-1I20P*_57IJ5.
M%*$/]!!K^CWU6]P[Q)XO,/Y(M\#Q(G>.=@SRY&1=7Q]!YD@,SY_,D9432@6*
M<G+E<LE,(\IU0!=$RJ+?T+UDW`-33D>0YSD;..;D*WB8H4"!H6AM_3IM542(
MFGH:$_`Z@7%L7X\Q5[)!QE[%\P=Q<K.MQ<4K\VYFDDE`K]0J!7U%=65ZA6I_
%IIIK_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
